Integrated Biological Markers for the Prediction of Treatment Response in Depression: A Pilot Study
Phase of Trial: Phase III
Latest Information Update: 17 May 2018
At a glance
- Drugs Escitalopram (Primary) ; Aripiprazole; Quetiapine
- Indications Major depressive disorder
- Focus Biomarker; Pharmacodynamics
- Acronyms CAN-BIND-1
- 04 May 2018 Status changed from active, no longer recruiting to completed.
- 12 Oct 2016 Status changed from recruiting to active, no longer recruiting.
- 27 Nov 2013 Planned end date changed from 1 Aug 2015 to 1 Aug 2018 as reported by ClinicalTrials.gov.